Lisa P. Chu

1.4k total citations
8 papers, 786 citations indexed

About

Lisa P. Chu is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Lisa P. Chu has authored 8 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Hematology and 3 papers in Immunology. Recurrent topics in Lisa P. Chu's work include Acute Myeloid Leukemia Research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and interferon and immune responses (1 paper). Lisa P. Chu is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and interferon and immune responses (1 paper). Lisa P. Chu collaborates with scholars based in United States, Spain and Sweden. Lisa P. Chu's co-authors include А.П. Продеус, Christopher C. Goodnow, Olga Pozdnyakova, Elisabeth M. Alicot, Liming Shen, Michael C. Carroll, Siegfried Goerg, Benjamin L. Ebert, Rebekka K. Schneider and Rafael Kramann and has published in prestigious journals such as Nature Medicine, The Journal of Experimental Medicine and Blood.

In The Last Decade

Lisa P. Chu

8 papers receiving 772 citations

Peers

Lisa P. Chu
Comparison fields: 5 of 60
  • Immunology 348
  • Hematology 260
  • Molecular Biology 243
  • Epidemiology 128
  • Oncology 103
Replace Anouk Caraux with:
Anouk Caraux France
Duy T. Le United States
Wan Cheung Cheung United States
Yoshihito Hayami Japan
Takeki Mitsui Japan
F. García‐Sánchez Spain
Noemi F. Pereira Brazil
Paul Guglielmi France
Barbara H. Barendregt Netherlands
Miguel A. R. Marcos Spain
Anouk Caraux France View profile →
Citations per field, relative to Lisa P. Chu
Lisa P. Chu · 1×
Citations per year, relative to Lisa P. Chu
Lisa P. Chu · 1×

Countries citing papers authored by Lisa P. Chu

Since Specialization
Citations

This map shows the geographic impact of Lisa P. Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa P. Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa P. Chu more than expected).

Fields of papers citing papers by Lisa P. Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa P. Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa P. Chu. The network helps show where Lisa P. Chu may publish in the future.

Co-authorship network of co-authors of Lisa P. Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa P. Chu. A scholar is included among the top collaborators of Lisa P. Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa P. Chu. Lisa P. Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
# Work Indexed citations
1 5
2 1
3 169
4 137
5 69
6 1
7 284
8 120

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026